research product . Other ORP type . 2021

Evaluation and development of Artificial Intelligence tools to assess COVID-19 Severe Acute4 Respiratory Syndrome from chest imaging

Lekhasree Narayanagari;
Open Access English
  • Published: 01 Sep 2021
  • Country: Canada
Abstract
Chest CT is being more widely used as a diagnostic test for COVID-19 Severe Acute Respiratory Syndrome-related lung disease. Artificial intelligence (AI) has the ability to assist in the rapid assessment of CT scans for COVID-19 Severe Acute Respiratory Syndrome findings from other clinical entities. Here that a group of deep learning al- gorithms trained on a diverse multinational cohort of 1280 patients to localize parietal lung parenchyma followed by classification of COVID-19 Severe Acute Respiratory Syndrome can achieve up to 90.8 percent accuracy, with 84 percent sensitivity and 93 percent specificity, as measured in an independent test set (not included i...
Persistent Identifiers
Subjects
free text keywords: Artificial intelligence, COVID-19, Severe Acute Respiratory Syndrome, SARS, Chest Imaging
Related Organizations
Any information missing or wrong?Report an Issue